GlassScriptPhysician profile
Tabassum Hanif
NPI 1164453783
$6,041.14
in general payments reported to CMS, 2019-2025
32 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what 81% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $340 · 2021: $750 · 2022: $971 · 2023: $1,131 · 2024: $879 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,083 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,083.47 |
| Education | $158.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,398.00 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,384.72 | 2019-2025 | Nucala, Trelegy Ellipta |
| Harmony Biosciences LLC | $538.70 | 2021-2024 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.74 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $308.86 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Avadel Cns Pharmaceuticals, LLC | $242.02 | 2024-2025 | Lumryz |
| Genentech USA, INC. | $200.27 | 2019-2023 | Xolair |
| Regeneron Healthcare Solutions, INC. | $172.10 | 2022-2024 | Dupixent |
| Mylan Specialty L.P. | $134.98 | 2019-2024 | Yupelri |
| Pulmonx Corporation | $130.35 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Genzyme Corporation | $95.56 | 2021-2025 | |
| Baxter Healthcare | $89.94 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $89.36 | 2023-2025 | Vest Therapy Und, Amara Cushions |
| Novartis Pharmaceuticals Corporation | $87.47 | 2019-2025 | |
| Insmed, INC. | $86.57 | 2022-2025 | Arikayce, Brinsupri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $86.46 | 2019-2020 | |
| Merz North America, INC. | $86.39 | 2020 | |
| Merck Sharp & Dohme LLC | $71.24 | 2021-2025 | Zerbaxa |
| Grifols USA, LLC | $71.09 | 2019-2024 | Prolastin-C Liquid |
| Electromed, INC. | $59.05 | 2022-2025 | Smartvest |
| Abbvie INC. | $55.97 | 2024-2025 | |
| Inogen, INC. | $42.49 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Viatris Specialty LLC | $39.99 | 2025 | Yupelri |
| Amgen INC. | $39.85 | 2022-2025 | Tezspire |
| Ani Pharmaceuticals, INC. | $31.34 | 2025 | Purified Cortrophin Gel |
| Advanced Respiratory, INC | $29.07 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.92 | 2022 | |
| Axsome Therapeutics, INC. | $18.31 | 2023 | Sunosi |
| Vapotherm INC | $17.01 | 2021 | |
| La Jolla Pharmaceutical Company | $15.40 | 2024 | Giapreza |
| Melinta Therapeutics, LLC | $14.67 | 2019 | |
| Inspire Medical Systems, INC. | $14.25 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabassum Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.